Emulate's Grant

Emulate raised a round of funding on June 20, 2017. Investors include National Center For Advancing Translational Sciences.

Emulate is a private company focused on commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for mimicking true human physiology so that responses t…

Articles about Emulate's Grant: